About
Dr. Victor Bustos is the co-founder and CEO of Refoxy Pharmaceuticals, a Germany-based preclinical biotech company developing FOXO3 activators for age-related diseases, initially focused on idiopathic pulmonary fibrosis. Refoxy says he co-founded the company with Prof. Wolfgang Link in partnership with Apollo Health Ventures. Public sources reviewed describe him as a biotech entrepreneur and company builder, not as a fund manager or personal capital allocator.
Areas of interest
longevityaging biologybiotechdrug discoveryFOXO3 therapeuticsfibrosisage-related diseases